Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.
Dattola A, Bernardini N, Caldarola G, Coppola R, De Simone C, Giordano D, Giunta A, Moretta G, Pagnanelli G, Panasiti V, Persechino S, Potenza C, Trovato F, Zangrilli A, Bianchi L, Pellacani G, Peris K, Richetta AG. Dattola A, et al. Among authors: persechino s. Dermatol Pract Concept. 2024 Jul 1;14(3):e2024166. doi: 10.5826/dpc.1403a166. Dermatol Pract Concept. 2024. PMID: 39122514 Free PMC article.
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.
Papini M, Cusano F, Romanelli M, Burlando M, Stinco G, Girolomoni G, Peris K, Potenza C, Offidani A, Bartezaghi M, Aloisi E, Costanzo A; SUPREME study group. Papini M, et al. Br J Dermatol. 2019 Aug;181(2):413-414. doi: 10.1111/bjd.18013. Epub 2019 May 29. Br J Dermatol. 2019. PMID: 31001812 Clinical Trial. No abstract available.
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.
Dattola A, Bernardini N, Anedda J, Atzori L, Bonifati C, Bruni PL, Graceffa D, Giordano D, Molinelli E, Moretta G, Mugheddu C, Offidani A, Pagnanelli G, Pallotta S, Papini M, Persechino S, Richetta AG, Tolino E, Pellacani G, Potenza C. Dattola A, et al. Among authors: persechino s. Ital J Dermatol Venerol. 2024 Aug;159(4):467-469. doi: 10.23736/S2784-8671.24.07921-0. Epub 2024 Jun 3. Ital J Dermatol Venerol. 2024. PMID: 38829271 No abstract available.
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study.
Dattola A, Bernardini N, Svara F, Balato A, Caldarola G, D'Amico D, De Simone C, Di Brizzi EV, Esposito M, Giofrè C, Giordano D, Guarneri C, Loconsole F, Lora V, Moretta G, Orsini D, Persechino S, Potenza C, Ragonesi S, Pellacani G, Peris K, Fargnoli MC, Richetta AG. Dattola A, et al. Among authors: persechino s. J Dermatolog Treat. 2024 Dec;35(1):2420825. doi: 10.1080/09546634.2024.2420825. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462515 Free article.
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: persechino s. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
Poikiloderma vasculare atrophicans: report of a case of long duration.
Di Guardo A, Maretti G, Ascione A, Balampanos CG, Persechino F, Giordano D, De Marco G, Persechino S. Di Guardo A, et al. Among authors: persechino s. Clin Exp Dermatol. 2024 Oct 24;49(11):1441-1444. doi: 10.1093/ced/llae237. Clin Exp Dermatol. 2024. PMID: 38913671 No abstract available.
105 results